Journal of the Neurological Sciences
Volume 292, Issue 1 , Pages 63-71, 15 May 2010

Nerve excitability changes after intravenous immunoglobulin infusions in multifocal motor neuropathy and chronic inflammatory demyelinating neuropathy

  • Delphine Boërio

      Affiliations

    • Service de Physiologie, Explorations Fonctionnelles, Hôpital Henri Mondor, Assistance Publique, Hôpitaux de Paris, Créteil, France
    • EA 4391, Excitabilité Nerveuse et Thérapeutique, Université Paris 12, Créteil, France
    • Institut de Myologie, Hôpital Pitié-Salpêtrière, Paris, France
  • ,
  • Alain Créange

      Affiliations

    • EA 4391, Excitabilité Nerveuse et Thérapeutique, Université Paris 12, Créteil, France
    • Service de Neurologie, Hôpital Henri Mondor, Assistance Publique, Hôpitaux de Paris, Créteil, France
  • ,
  • Jean-Yves Hogrel

      Affiliations

    • Institut de Myologie, Hôpital Pitié-Salpêtrière, Paris, France
  • ,
  • Antoine Guéguen

      Affiliations

    • EA 4391, Excitabilité Nerveuse et Thérapeutique, Université Paris 12, Créteil, France
    • Service de Neurologie, Hôpital Henri Mondor, Assistance Publique, Hôpitaux de Paris, Créteil, France
  • ,
  • Dominique Bertrand

      Affiliations

    • Unité de Sensométrie et de Chimiométrie, ENITIAA-INRA, Nantes, France
  • ,
  • Jean-Pascal Lefaucheur

      Affiliations

    • Service de Physiologie, Explorations Fonctionnelles, Hôpital Henri Mondor, Assistance Publique, Hôpitaux de Paris, Créteil, France
    • EA 4391, Excitabilité Nerveuse et Thérapeutique, Université Paris 12, Créteil, France
    • Corresponding Author InformationCorresponding author. Service Physiologie, Explorations Fonctionnelles, Hôpital Henri Mondor, 51 avenue de Lattre de Tassigny, 94010 Créteil cedex, France. Tel.: +33 1 4981 2694; fax: +33 1 4981 4660.

Received 18 July 2009; received in revised form 22 December 2009; accepted 2 February 2010. published online 11 March 2010.

Abstract 

Intravenous immunoglobulin (IVIg) infusions may provide clinical benefits in multifocal motor neuropathy (MMN) and chronic inflammatory demyelinating polyneuropathy (CIDP). The short delay in the clinical response to IVIg therapy is not consistent with a process of remyelination or axonal regeneration. We assessed whether or not the efficacy of IVIg infusions in MMN and CIDP could reflect changes in axonal membrane properties and nerve excitability. Ulnar motor nerve excitability was studied before and after three to five consecutive days of IVIg infusions (0.4g/kg/day) in 10 patients with MMN, 10 patients with CIDP, and 10 neurological controls (CTRLs). Excitability recovery cycle, stimulus–response and strength–duration properties were investigated. The recovery cycle parameters (absolute and relative refractory period durations, refractoriness and supernormality) were similar in all groups and did not change after IVIg infusions. At baseline, patients with CIDP, but not with MMN, showed a reduced strength–duration time constant (chronaxie) and increased rheobase when compared to CTRLs. After IVIg infusions, strength–duration time constant remained stable in CTRLs, but decreased in patients with MMN or CIDP. Rheobase increased in the three groups after treatment. The decreased strength–duration time constant after IVIg infusions in patients with MMN or CIDP could reflect a reduction of persistent Na+ current, able to limit intraaxonal Na+ accumulation and then to produce neuroprotective effects. However, this could also reflect compensatory mechanisms that did not directly underlie the therapeutic effect. Whatever the underlying process, this result revealed that IVIgs were able to produce early nerve excitability changes.

Keywords: Chronic inflammatory demyelinating polyneuropathy, Conduction block, Intravenous immunoglobulin, Multifocal motor neuropathy, Rheobase, Sodium conductance, Strength–duration time constant, Supernormality

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0022-510X(10)00059-6

doi:10.1016/j.jns.2010.02.002

Journal of the Neurological Sciences
Volume 292, Issue 1 , Pages 63-71, 15 May 2010